BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7521638)

  • 1. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
    Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
    Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAN IMMUNOHISTOCHEMISTRY DISTINGUISH BETWEEN PRIMARY AND METASTATIC HEPATIC CARCINOMA?
    Mishra R; Deshpande GU
    Med J Armed Forces India; 1995 Apr; 51(2):128-129. PubMed ID: 28769266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
    Chiaramondia M; Ceppa P; Baccini P; Badini A; Castellaneta A
    Pathologica; 1993; 85(1100):687-99. PubMed ID: 8170717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
    Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB
    Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case.
    Caruso RA
    Eur J Basic Appl Histochem; 1991; 35(2):203-9. PubMed ID: 1722709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?
    Malouf G; Falissard B; Azoulay D; Callea F; Ferrell LD; Goodman ZD; Hayashi Y; Hsu HC; Hubscher SG; Kojiro M; Ng IO; Paterson AC; Reynes M; Zafrani ES; Emile JF
    J Clin Pathol; 2009 Jun; 62(6):519-24. PubMed ID: 19155239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
    Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
    Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH; Hughes JH; De Young BR
    Cancer; 1999 Oct; 87(5):295-8. PubMed ID: 10536355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.